# Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-trial-of-the-anti-fgf23-antibody-krn23-in-x-linked-hypophosphatemia/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thomas O. Carpenter,Erik A. Imel,Mary D. Ruppe,Thomas J. Weber,Mark A. Klausner,Margaret M. Wooddell,Tetsuyoshi Kawakami,Takahiro Ito,Xiaoping Zhang,Jeffrey S. Humphrey,Karl Insogna,Munro Peacock |
| Citations | 319 |
| DOI | 10.1172/jci72829 |
| Fields | Medicine,Nursing |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2090490099 |
| PMID | 24569459 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Erik A. Imel](https://scholariq.org/researchers/erik-a-imel/)

## Paper primary topic

- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

## Paper topics

- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Magnesium in Health and Disease](https://scholariq.org/topics/magnesium-in-health-and-disease/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.